DE69704759T2 - Ellipticinederivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen - Google Patents
Ellipticinederivate, ihre Herstellung und diese enthaltende pharmazeutische ZubereitungenInfo
- Publication number
- DE69704759T2 DE69704759T2 DE69704759T DE69704759T DE69704759T2 DE 69704759 T2 DE69704759 T2 DE 69704759T2 DE 69704759 T DE69704759 T DE 69704759T DE 69704759 T DE69704759 T DE 69704759T DE 69704759 T2 DE69704759 T2 DE 69704759T2
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- preparation
- pharmaceutical preparations
- preparations containing
- ellipticine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- CTSPAMFJBXKSOY-UHFFFAOYSA-N ellipticine Chemical class N1=CC=C2C(C)=C(NC=3C4=CC=CC=3)C4=C(C)C2=C1 CTSPAMFJBXKSOY-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9616166A FR2757858B1 (fr) | 1996-12-30 | 1996-12-30 | Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69704759D1 DE69704759D1 (de) | 2001-06-13 |
| DE69704759T2 true DE69704759T2 (de) | 2002-02-28 |
Family
ID=9499262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69704759T Expired - Fee Related DE69704759T2 (de) | 1996-12-30 | 1997-12-22 | Ellipticinederivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5919791A (de) |
| EP (1) | EP0850939B1 (de) |
| JP (1) | JPH10195073A (de) |
| CN (1) | CN1098851C (de) |
| AT (1) | ATE201023T1 (de) |
| AU (1) | AU735626B2 (de) |
| BR (1) | BR9706491A (de) |
| CA (1) | CA2227513C (de) |
| DE (1) | DE69704759T2 (de) |
| DK (1) | DK0850939T3 (de) |
| ES (1) | ES2157542T3 (de) |
| FR (1) | FR2757858B1 (de) |
| GR (1) | GR3036243T3 (de) |
| HK (1) | HK1011863A1 (de) |
| HU (1) | HUP9702541A3 (de) |
| NO (1) | NO309654B1 (de) |
| NZ (1) | NZ329511A (de) |
| PL (1) | PL324070A1 (de) |
| PT (1) | PT850939E (de) |
| ZA (1) | ZA9711708B (de) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2436786A1 (fr) * | 1978-09-21 | 1980-04-18 | Anvar | Nouveaux derives des pyrido (4,3-b) carbazoles (ellipticines), substitues en position 1 par une chaine polyaminee, leur obtention et leur application a titre de medicaments |
| US4851417A (en) * | 1988-05-26 | 1989-07-25 | Rensselaer Polytechnic Institute | 9-substituted 6H-pyrido[4,3-b]carbazoles |
| FR2696465B1 (fr) * | 1992-10-02 | 1994-12-23 | Adir | Nouveaux dérivés d'ellipticine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| AU666416B2 (en) * | 1993-01-29 | 1996-02-08 | Tanabe Seiyaku Co., Ltd. | Ellipticine derivative and process for preparing the same |
-
1996
- 1996-12-30 FR FR9616166A patent/FR2757858B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-18 JP JP9349006A patent/JPH10195073A/ja active Pending
- 1997-12-22 EP EP97403120A patent/EP0850939B1/de not_active Expired - Lifetime
- 1997-12-22 ES ES97403120T patent/ES2157542T3/es not_active Expired - Lifetime
- 1997-12-22 DK DK97403120T patent/DK0850939T3/da active
- 1997-12-22 AT AT97403120T patent/ATE201023T1/de not_active IP Right Cessation
- 1997-12-22 DE DE69704759T patent/DE69704759T2/de not_active Expired - Fee Related
- 1997-12-22 PT PT97403120T patent/PT850939E/pt unknown
- 1997-12-24 NZ NZ329511A patent/NZ329511A/xx unknown
- 1997-12-29 HU HU9702541A patent/HUP9702541A3/hu unknown
- 1997-12-29 US US08/998,922 patent/US5919791A/en not_active Expired - Fee Related
- 1997-12-29 PL PL97324070A patent/PL324070A1/xx unknown
- 1997-12-29 NO NO976101A patent/NO309654B1/no not_active IP Right Cessation
- 1997-12-29 CA CA002227513A patent/CA2227513C/fr not_active Expired - Fee Related
- 1997-12-29 CN CN97123471A patent/CN1098851C/zh not_active Expired - Fee Related
- 1997-12-30 AU AU49307/97A patent/AU735626B2/en not_active Ceased
- 1997-12-30 ZA ZA9711708A patent/ZA9711708B/xx unknown
- 1997-12-30 BR BR9706491A patent/BR9706491A/pt not_active IP Right Cessation
-
1998
- 1998-12-10 HK HK98113128A patent/HK1011863A1/xx not_active IP Right Cessation
-
2001
- 2001-07-19 GR GR20010401092T patent/GR3036243T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9702541A3 (en) | 1998-11-30 |
| HK1011863A1 (en) | 1999-07-23 |
| NO976101L (no) | 1998-07-01 |
| DE69704759D1 (de) | 2001-06-13 |
| GR3036243T3 (en) | 2001-10-31 |
| DK0850939T3 (da) | 2001-08-06 |
| PT850939E (pt) | 2001-09-28 |
| NZ329511A (en) | 1998-10-28 |
| NO976101D0 (no) | 1997-12-29 |
| ES2157542T3 (es) | 2001-08-16 |
| AU4930797A (en) | 1998-07-02 |
| ZA9711708B (en) | 1998-06-25 |
| HUP9702541A2 (hu) | 1998-08-28 |
| ATE201023T1 (de) | 2001-05-15 |
| CN1098851C (zh) | 2003-01-15 |
| FR2757858B1 (fr) | 1999-01-29 |
| US5919791A (en) | 1999-07-06 |
| PL324070A1 (en) | 1998-07-06 |
| CA2227513A1 (fr) | 1998-06-30 |
| FR2757858A1 (fr) | 1998-07-03 |
| HU9702541D0 (en) | 1998-03-02 |
| EP0850939B1 (de) | 2001-05-09 |
| CA2227513C (fr) | 2003-04-29 |
| CN1188766A (zh) | 1998-07-29 |
| JPH10195073A (ja) | 1998-07-28 |
| EP0850939A1 (de) | 1998-07-01 |
| BR9706491A (pt) | 1999-05-18 |
| AU735626B2 (en) | 2001-07-12 |
| NO309654B1 (no) | 2001-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2081187T3 (es) | Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| DE3686483T2 (de) | Arzneimittel. | |
| ATE143598T1 (de) | Arzneimittellösung enhaltend derivate von fk506 | |
| ES2079534T3 (es) | Derivados de polietilenglicol, sus peptidos modificados, metodos para producirlos y uso de los peptidos modificados. | |
| ATE76747T1 (de) | Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen. | |
| ES2190469T3 (es) | Derivados de isocumarina y su uso en farmacos. | |
| DE69111138T2 (de) | Heterocyclische Verbindungen mit antiemetischer und Migräne unterdrückender Wirkung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen. | |
| DE68917485T2 (de) | Pyridazinon-Derivate und diese enthaltende pharmazeutische Zubereitungen. | |
| ES2118203T3 (es) | Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| ES2103440T3 (es) | Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| ES2077473T3 (es) | Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| FI910924A0 (fi) | Nya propanaminer, framstaellning av dessa och anvaendning av dessa foer terapeutiska aendamaol, i synnerhet som diarremediciner. | |
| DE69704759T2 (de) | Ellipticinederivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| ES2095714T3 (es) | Nuevas amino-alquil-cromonas, sus procedimientos de preparacion y las composiciones farmaceuticas que las contienen. | |
| KR920003972A (ko) | 프로스타시클린 화합물을 이용한 백내장 치료 | |
| ES2062313T3 (es) | 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos. | |
| NO872982L (no) | Nye tetracykliske indolderivater. | |
| DK0471856T3 (da) | 15-Deoxyprostaglandin-derivater | |
| DE68906827T2 (de) | Phenothiazinderivate, deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. | |
| NO178302C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte 3-tia- henholdsvis 3-oksa-alkylflavoner, samt mellomprodukter for fremgangsmåten | |
| ES2123038T3 (es) | Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR |
|
| 8339 | Ceased/non-payment of the annual fee |